Paul Newhouse

October 25, 2023

Vanderbilt Center for Cognitive Medicine named Alzheimer’s Clinical Trials Consortium Member Site

The Vanderbilt Center for Cognitive Medicine has been named an Alzheimer’s Clinical Trials Consortium Member Site.

By Danny Bonvissuto
April 21, 2022

Taylor, Newhouse, Petrie honored by geriatric psychiatry association

Vanderbilt’s Warren Taylor, MD, MHSc, Paul Newhouse, MD, and William Petrie, MD, were recently honored at the 2022 American Association for Geriatric Psychiatry (AAGP) Awards.

By Emily Stembridge
January 5, 2022

Vanderbilt Kennedy Center to host Jan. 25 workshop on Down syndrome and Alzheimer’s disease

By VUMC News and Communications
July 26, 2021

Mood and cognition after chemotherapy

Validation of cognitive complaints appears to improve mood in patients with persistent chemotherapy-cognitive impairment, Vanderbilt researchers report.

By Emily Stembridge
October 15, 2020

Study explores nicotine patch to treat late-life depression

Backed by nearly $5 million in funding, researchers from Vanderbilt University Medical Center are testing to see whether transdermal nicotine patches can improve mood, forgetfulness and attentiveness in adults over 60 with a diagnosis of depression.

By Kelsey Herbers
July 30, 2020

Memory complaints linked to changes in brain structure in postmenopausal women

Memory complaints in younger postmenopausal women are associated with differences in brain structure and may serve as an early marker for risk of future cognitive decline, according to a study published June 22 in Menopause by Vanderbilt University Medical Center researchers.

By Kelsey Herbers
February 12, 2020

Study seeks link between menopause, Alzheimer’s

Beginning this month, researchers from VUMC and the University of Vermont are launching a study to examine whether cognitive changes that occur at menopause for some women are related to an increased risk for Alzheimer's disease.
By Kelsey Herbers
November 2, 2017

Study explores nicotine patch to treat mild cognitive impairment

Three years ago Reece Dean, of Nashville’s Bellevue community, retired at age 69 from a career as a busy truck driver. Mary Ann, his wife, began to notice some changes in his memory and behavior since he was home more consistently.
By Nancy Humphrey
August 7, 2017

Vanderbilt begins Phase 1 trials of new Alzheimer’s drug

Developed at Vanderbilt, VU319 is designed to precisely target a specific neuron receptor associated with cognitive function while avoiding potentially dangerous side effects.
By Bill Snyder
March 2, 2017

Clues found to recurrent depression

Women who have had repeated depressive episodes tend to pay more attention to negative emotional information, suggesting that they may benefit from cognitive therapy to build new, more positive pathways in their brains.
By Bill Snyder
December 27, 2016

Investigational new drug for Alzheimer’s scheduled for first study in humans

Vanderbilt University scientists have received notification from the U.S. Food and Drug Administration that testing in humans may proceed for an investigational new drug for Alzheimer's disease after more than 10 years of research by scientists at Vanderbilt University and Vanderbilt University Medical Center.
By Craig Boerner
October 29, 2015

Study explores nicotine patch to treat memory loss

Vanderbilt University Medical Center has received a $9.4 million grant from the National Institute on Aging (NIA) to test the effectiveness of a transdermal nicotine patch in improving memory loss in older adults with mild cognitive impairment (MCI), a precursor to Alzheimer’s disease.
By Nancy Humphrey
December 16, 2013

Cancer drug enhances cognition

The breast cancer drug tamoxifen improves cognitive performance in post-menopausal women.
By Leigh MacMillan